Resource Library

Coordinating Implementation Science for CAB for PrEP: Bridging from the HPTN 083 and 084 Open Label Extensions to Implementation

This document summarises key takeaways from the BioPIC Think Tank on early insights from the HIV Prevention Trials Network (HPTN) 083 and 084 studies’ Open Label Extensions, looking at effectiveness of cabotegravir for PrEP as HIV prevention.

Research

Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction Report

This report was from the BioPIC Think Tank, Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction. As new HIV prevention products move closer to entering the market, there is an opportunity to design choice-based programs that apply lessons and successes from HIV and FP…

Demand Creation/Marketing

Safety and Efficacy of Long-Acting Injectable Cabotegravir as Preexposure Prophylaxis To Prevent HIV Acquisition

This journal article from AIDS reviewed existing evidence to determine the efficacy and safety of CAB for PrEP in order to inform global guidelines.

Monitoring & Evaluation

Important Steps for PrEP Uptake Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil

This journal article from PLOS ONE analyzed the PrEP uptake process and factors associated with daily oral PrEP initiation among adolescent men who have sex with men and transgender women in Brazil.

Monitoring & Evaluation

HIV Care Providers’ Familiarity, Concerns, and Attitudes About HIV PrEP in Colombia: Insights From the PrEP-Col-Study

This journal article from AIDS Care examined PrEP awareness and familiarity, comfort with PrEP-related activities, perceived barriers for PrEP implementation, concerns, and attitudes in Colombia.

Monitoring & Evaluation

Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction Slides

These slides were featured at the BioPIC Think Tank, Shaping and Strengthening Markets for a New Era of Choice-based HIV/SRH Programming: Lessons from HIV & FP product introduction. As new HIV prevention products move closer to entering the market, there is an opportunity to design choice-based programs that apply lessons and successes from HIV and…

Demand Creation/Marketing

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

This journal article from Antimicrobial Agents and Chemo Therapy shares an extended report on HIV infections that occurred up to 1 year after study unblinding (18 in the CAB arm and 34 in the TDF-FTC arm).

Monitoring & Evaluation

Uptake and Continuation of HIV Pre-Exposure Prophylaxis Among Women of Reproductive Age in Two Health Facilities in Kisumu County, Kenya

This article from Journal of the International AIDS Society follows the uptake and continuation of oral PrEP among women 15–49 years in two health facilities in Kisumu County, Kenya.

Monitoring & Evaluation

HIV Prevention Plus Plus: Developing Options that Meet the Full Range of our Sexual and Reproductive Health Needs

Despite a dynamic research and development (R&D) pipeline for prevention products, male and female condoms remain the only multi-purpose prevention technologies (MPTs) currently available. Yet MPTs are an integral part of the HIV prevention advocacy agenda. For decades, advocates have pushed for products to be developed that simultaneously prevent HIV, other sexually transmitted infections (STIs)…

Private Sector Delivery Strategy for the Dual Prevention Pill: Kenya and Zimbabwe

This strategy was authored by the DPP Consortium to prepare for market entry of the DPP (Dual Prevention Pill) in Kenya and Zimbabwe.

Service Delivery